97 related articles for article (PubMed ID: 556829)
21. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
[TBL] [Abstract][Full Text] [Related]
22. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
Ramasamy R; Joseph B; Whittall T
Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
[TBL] [Abstract][Full Text] [Related]
23. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis.
Zhang Y; Burger D; Saruhan G; Jeannet M; Steck AJ
Neurology; 1993 Feb; 43(2):403-7. PubMed ID: 7679782
[TBL] [Abstract][Full Text] [Related]
24. Biochemical findings in multiple sclerosis. V. Transformation of lymphocytes from patients with multiple sclerosis by human basic protein.
Gosseye-Lissoir F; Delmotte P; Carton H
J Neurol; 1977 Oct; 216(3):197-205. PubMed ID: 72138
[TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis. Presenting an odd autoantigen.
Steinman L
Nature; 1995 Jun; 375(6534):739-40. PubMed ID: 7541112
[No Abstract] [Full Text] [Related]
26. Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid.
Söderström M; Link H; Sun JB; Fredrikson S; Wang ZY; Huang WX
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):544-51. PubMed ID: 7515411
[TBL] [Abstract][Full Text] [Related]
27. Multiple sclerosis, Guillain-Barré syndrome and myelin basic protein-specific cellular antibody.
Johnson AB; Dal Canto MC
Nature; 1976 Dec; 264(5585):453-4. PubMed ID: 1004578
[No Abstract] [Full Text] [Related]
28. [Pathogenesis of multiple sclerosis. Antibody dependent cytotoxicity of lymphocytes against myelin basic proteins in multiple sclerosis].
Frick E; Stickl H
Fortschr Med; 1977 Oct; 95(37):2235-41. PubMed ID: 914178
[TBL] [Abstract][Full Text] [Related]
29. Delayed hypersensitivity to human encephalitogenic protein as assayed by agarose leucocyte migration in multiple sclerosis patients.
Clanet M; Kuhlein E; Rascol A; Abbal M; Ohayon E
J Neurol Sci; 1979 Jul; 42(2):203-13. PubMed ID: 90126
[TBL] [Abstract][Full Text] [Related]
30. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
Sarchielli P; Di Filippo M; Candeliere A; Chiasserini D; Mattioni A; Tenaglia S; Bonucci M; Calabresi P
J Neuroimmunol; 2007 Aug; 188(1-2):146-58. PubMed ID: 17628700
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
32. Multiple sclerosis: cell-mediated immunity to human brain gangliosides.
Beraud E; Golstein MM; Viallet F; Sela BA; Galibert R; Durbec JP; Khalil R; Gastaut JL; Richard P; Roux H
Autoimmunity; 1990; 6(1-2):13-21. PubMed ID: 2129765
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte transformation in the presence of myelin basic protein in multiple sclerosis and control subjects.
Hughes RA; Gray IA; Clifford-Jones R; Stern MA
Acta Neurol Scand; 1979 Aug; 60(2):65-76. PubMed ID: 91302
[TBL] [Abstract][Full Text] [Related]
34. [Immunological studies in multiple sclerosis].
Rysková O; Pekárek J; Vejbora O; Chromová L
Cesk Neurol Neurochir; 1981 Mar; 44(2):108-15. PubMed ID: 6165493
[No Abstract] [Full Text] [Related]
35. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
Mastronardi FG; Moscarello MA
J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
[TBL] [Abstract][Full Text] [Related]
36. Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.
Börnsen L; Romme Christensen J; Ratzer R; Hedegaard C; Søndergaard HB; Krakauer M; Hesse D; Nielsen CH; Sorensen PS; Sellebjerg F
PLoS One; 2015; 10(3):e0118830. PubMed ID: 25738751
[TBL] [Abstract][Full Text] [Related]
37. Myelin basic protein: what role in MS?
JAMA; 1978 Jul; 240(1):15. PubMed ID: 77920
[No Abstract] [Full Text] [Related]
38. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
Hafler DA; Benjamin DS; Burks J; Weiner HL
J Immunol; 1987 Jul; 139(1):68-72. PubMed ID: 2438352
[TBL] [Abstract][Full Text] [Related]
39. Leukocyte migration in agarose, a study on multiple sclerosis.
Bergstrand H; Källén B; Nilsson O
Acta Allergol; 1975 Jul; 30(2-3):150-66. PubMed ID: 50704
[TBL] [Abstract][Full Text] [Related]
40. Direct leukocyte migration inhibition in multiple sclerosis--a possible assessment of activity.
Day MP; Day JH; Mann PL
Can J Neurol Sci; 1976 May; 3(2):99-103. PubMed ID: 1268769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
